icon-    folder.gif   Conference Reports for NATAP  
 
  Back grey_arrow_rt.gif
 
 
 
 
 
Doravirine Resistance Profile in Clinical Isolates and Impact of Baseline NNRTI Resistance-Associated Mutations Observed in Treatment-Naïve Participants from Phase 2 and 3 Clinical Trials
 
 
  Ernest Asante-Appiah1; Johnny Lai2; Qing Li1; DongmeiYang2; Elizabeth Anne Martin1; Peter Sklar1; Daria Hazuda1; Christos J. Petropoulos2; Charles Walworth2; Jay A. Grobler1 1Merck & Co., Inc., Kenilworth, NJ, USA. 2Monogram Biosciences, South San Francisco, CA, USA
 
23rd International AIDS Conference (AIDS 2020: Virtual), July 6-10, 2020. Reported by Jules Levin

0713201

0713202

0713203

0713204

0713205

0713206

0713207